Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology. | Front Pharmacol | 2020 | 32848787 | PubTator, text mining | PubMed |
| Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. | Nat Commun | 2020 | 32839463 | PubTator, text mining | PubMed |
| The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells. | Molecules | 2020 | 32825505 | PubTator, text mining | PubMed |
| Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer. | Int J Mol Sci | 2020 | 32824813 | PubTator, text mining | PubMed |
| Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study. | Cancers (Basel) | 2020 | 32823925 | PubTator, text mining | PubMed |
| Spontaneous mutations in the single TTN gene represent high tumor mutation burden. | NPJ Genom Med | 2020 | 32821429 | PubTator, text mining | PubMed |
| Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer. | Cancer | 2020 | 32809219 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| Colonic Adenocarcinoma at Advanced Stage in Adolescence: Report of 2 Cases. | Case Rep Pathol | 2020 | 32774969 | PubTator, text mining | PubMed |
| Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice. | Biochem Med (Zagreb) | 2020 | 32774122 | PubTator, text mining | PubMed |
| Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications. | Biomolecules | 2020 | 32764278 | PubTator, text mining | PubMed |
| DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers. | Int J Mol Sci | 2020 | 32756484 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. | Int J Mol Sci | 2020 | 32752096 | PubTator, text mining | PubMed |
| Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma. | Cancers (Basel) | 2020 | 32751679 | PubTator, text mining | PubMed |
| Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. | Diagnostics (Basel) | 2020 | 32731384 | PubTator, text mining | PubMed |
| Whole exome profiling and mutational analysis of Ocular Surface Squamous Neoplasia. | Ocul Surf | 2020 | 32717381 | PubTator, text mining | PubMed |
| Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells. | Cell Death Dis | 2020 | 32709853 | PubTator, text mining | PubMed |
| The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers. | Genes (Basel) | 2020 | 32708251 | PubTator, text mining | PubMed |
| Antibodies specific to ferritin light chain polypeptide are frequently detected in patients with immune‑related pancytopenia. | Mol Med Rep | 2020 | 32705249 | PubTator, text mining | PubMed |
| Post-transcriptional air pollution oxidation to the cholesterol biosynthesis pathway promotes pulmonary stress phenotypes. | Commun Biol | 2020 | 32699268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=34